Nathaniel Zilkha, a principal at KKR, spoke at The Deal's Healthcare Dealmaking Symposium about the counter-cyclical dynamics in healthcare M&A that his firm is seeing.
Inside The Deal: Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.